Citations

Mayo Clinic

Showing 10 of 108572 citations.

Characterization of C3 in C3 glomerulopathy
Sethi, Sanjeev , Vrana, Julie A., Theis, Jason D. , Sethi, Amit , Kurtin, Paul J. , Smith, Richard J. , Fervenza, Fernando C. , Zhang, Yuzhou

Nephrology Dialysis Transplantation | August 9, 2016 | Volume: 32 | Issue: 3 | Pages: 459-465

10.1093/ndt/gfw290 | PMID 27507892 Get It

Abstract Background: C3 glomerulopathy (C3G) is caused by overactivity of the alternative pathway of complement that results in bright glomerular C3 staining with minimal or no deposition of immunoglobulins on immunofluorescence microscopy. Laser microdissection and mass spectrometry of the two subtypes, C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), have identified C3 as the predominant glomerular complement protein, although lesser amounts of C9, C5, C6, C7 and C8 are detectable. C3 plays a central role in complement activity, with its proteolytic cleavage first generating C3a and C3b, followed by inactivation of C3b generating iC3b (which includes C3α and C3β), which undergoes further breakdown yielding C3c and terminal breakdown fragment C3dg. The composition of C3 breakdown products in C3G is not known. Methods: In this study, we chose six cases each of C3GN and DDD to analyze the composition of C3 deposits. We analyzed the amino acid sequence of C3 spectra detected by mass spectrometry to determine the relative abundance of C3 fragments in C3G. Thus we were able to determine the amino acid sequences mapping to the various C3 activation products including C3dg, C3α (C3α1 and α2), and C3β that are part of C3b/iC3b/C3c. Results: C3dg is the predominant cleavage product detected with the highest amino acid coverage. The remaining amino acids map to C3α (C3α1 and α2) and C3β. Amino acids mapping to C3a and C3f are absent. Taken together, the C3α and C3β amino acids represent iC3b prior to or after C3c cleavage of C3dg. The C3 spectra for both C3GN and DDD are surprisingly similar. Conclusion: The finding of large amounts of C3dg suggests that C3b deposition in the glomerulus is an active process triggered by thioester binding of C3b to the glycocalyx overlying the glomerular endothelial cells and glomerular basement membrane. Regulatory protein-mediated inactivation of C3b results in the generation of iC3b. After additional cleavages, mostly C3dg remains.
Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias
Martin-Macintosh, Erica L., Johnson, Geoffrey B. , Cullen, Ethany L., Peller, Patrick J., Hunt, Christopher H. , Broski, Stephen M. , Johnson, Geoffrey B

American Journal of Roentgenology | August 9, 2016 | Volume: 207 | Issue: 4 | Pages: 883-895

10.2214/ajr.14.12910 | PMID 27504528 Get It

Chaperonin-Based Biolayer Interferometry To Assess the Kinetic Stability of Metastable, Aggregation-Prone Proteins
Lea, Wendy , O’Neil, Pierce T. , Machen, Alexandra J. , Naik, Subhashchandra , Chaudhri, Tapan, McGinn-Straub, Wesley, Tischer, Alexander , Auton, Matthew , Burns, Joshua R. , Baldwin, Michael R. , Khar, Karen R., Karanicolas, John , Fisher, Mark T., Auton, Matthew T, Auton, Matthew , Tischer, Alexander

Biochemistry | August 9, 2016 | Volume: 55 | Issue: 35 | Pages: 4885-4908

10.1021/acs.biochem.6b00293 | PMID 27505032 Get It

Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias
Martin-Macintosh, Erica L., Johnson, Geoffrey B. , Cullen, Ethany L., Peller, Patrick J., Hunt, Christopher H. , Broski, Stephen M. , Johnson, Geoffrey B

American Journal of Roentgenology | August 9, 2016 | Volume: 207 | Issue: 4 | Pages: 871-882

10.2214/ajr.14.12842 | PMID 27505704 Get It

Michael M. Todd, M.D., Recipient of the 2016 Excellence in Research Award
Warner, David S. , Lanier, William L.

Anesthesiology | August 9, 2016 | Volume: 125 | Issue: 4 | Pages: 641-644

10.1097/aln.0000000000001291 Get It

Lack of Utility of Anti‐tTG IgG to Diagnose Celiac Disease When Anti‐tTG IgA Is Negative
Absah, Imad , Rishi, Abdul , Gebrail, Rami, Snyder, Melissa R. , Murray, Joseph A.

Journal of Pediatric Gastroenterology and Nutrition | August 9, 2016 | Volume: 64 | Issue: 5 | Pages: 726-729

10.1097/mpg.0000000000001351 | PMID 28437323 Get It

ABSTRACTObjectives:Guidelines for diagnosing celiac disease (CD) recommend initial testing with a highly sensitive serologic test for anti–tissue transglutaminase immunoglobulin A antibodies (tTG IgA). When the probability of CD is high, IgA deficiency should be considered. The 2 approaches to address this include measuring “both tTG IgA and tTG IgG” or measuring “total IgA.” We aim to assess the utility of an isolated positive tTG IgG result in diagnosing CD.Methods:We conducted a retrospective review of patients undergoing serologic testing for CD from January 1997 to June 2014. Patients with positive tTG IgG and negative tTG IgA were included. Moreover, all patients who had any other positive CD‐specific serologic findings were excluded. Demographics, clinical presentation, tests, and biopsy results were recorded.Results:The indication for checking celiac serology was gastrointestinal symptoms in 172 of 233 patients, iron deficiency anemia in 12, and high‐risk screening in 48. Small bowel biopsy was performed in 178 patients (77%); 160 had normal results and 18 had histologic changes suggestive of enteropathy. Nine patients had increased intraepithelial lymphocytes, and 9 had partial villous atrophy. Only 6 cases of CD were, however, confirmed. The utility of isolated tTG IgG in diagnosis of CD was low at 3% (6/178).Conclusion:In this cohort of patients, the utility of isolated tTG IgG in diagnosing CD was low at 3%.
American Clinical Neurophysiology Society Guideline 6: Minimum Technical Standards for EEG Recording in Suspected Cerebral Death
Sabau, Dragos , Sullivan, Lucy R., Das, Rohit , Selioutski, Olga , Drislane, Frank W. , Tsuchida, Tammy N., Tatum, William O. , Stecker, Mark M, Stecker, Mark M. , Selioutski, Olga , Das, Rohit R

Journal of Clinical Neurophysiology | August 9, 2016 | Volume: 33 | Issue: 4 | Pages: 324-327

10.1097/wnp.0000000000000322 | PMID 27482789 Get It

Summary: This revision to the EEG Guidelines is an update incorporating current EEG technology and practice. The role of the EEG in making the determination of brain death is discussed as are suggested technical criteria for making the diagnosis of electrocerebral inactivity.
American Clinical Neurophysiology Society Guideline 7: Guidelines for EEG Reporting
Tatum, William O. , Ochoa, Juan G. , Cheek, Janna, Drislane, Frank W. , Tsuchida, Tammy N., Selioutski, Olga , Clary, Heidi M. Munger

Journal of Clinical Neurophysiology | August 9, 2016 | Volume: 33 | Issue: 4 | Pages: 328-332

10.1097/wnp.0000000000000319 | PMID 27482790 Get It

Summary: This EEG Guideline incorporates the practice of structuring a report of results obtained during routine adult electroencephalography. It is intended to reflect one of the current practices in reporting an EEG and serves as a revision of the previous guideline entitled “Writing an EEG Report.” The goal of this guideline is not only to convey clinically relevant information, but also to improve interrater reliability for clinical and research use by standardizing the format of EEG reports. With this in mind, there is expanded documentation of the patient history to include more relevant clinical information that can affect the EEG recording and interpretation. Recommendations for the technical conditions of the recording are also enhanced to include post hoc review parameters and type of EEG recording. Sleep feature documentation is also expanded upon. More descriptive terms are included for background features and interictal discharges that are concordant with efforts to standardize terminology. In the clinical correlation section, examples of common clinical scenarios are now provided that encourages uniformity in reporting. Including digital samples of abnormal waveforms is now readily available with current EEG recording systems and may be beneficial in augmenting reports when controversial waveforms or important features are encountered.
American Clinical Neurophysiology Society: EEG Guidelines Introduction
Tsuchida, Tammy N., Acharya, Jayant N. , Halford, Jonathan J. , Kuratani, John, Sinha, Saurabh R. , Tatum, William O. , Drislane, Frank W. , Stecker, Mark M. , Halford, Jonathan J

Journal of Clinical Neurophysiology | August 9, 2016 | Volume: 33 | Issue: 4 | Pages: 301-302

10.1097/wnp.0000000000000315 | PMID 27482792 Get It

Summary: This revision to the EEG Guidelines is an update incorporating current EEG technology and practice. “Standards of practice in clinical electroencephalography” (previously Guideline 4) has been removed. It is currently undergoing revision through collaboration among multiple medical societies and will become part of “Qualifications and Responsibilities of Personnel Performing and Interpreting Clinical Neurophysiology Procedures.” The remaining guidelines are reordered and renumbered.
Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling
Carpio, Lomeli R., Bradley, Elizabeth W. , Weivoda, Megan , Poston, Daniel , Dudakovic, Amel , Xu, Ming , Tchkonia, Tamar , Kirkland, James L. , Wijnen, André J. van , Oursler, Merry Jo, Shull, Lomeli C. , Weivoda, Megan M, Poston, Daniel D, van Wijnen, Andre J, McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J. , van Wijnen, Andre J , Bradley, Elizabeth W , Xu, Ming , Tchkonia, T

Science Signaling | August 9, 2016 | Volume: 9 | Issue: 440 | Pages: No page available

10.1126/scisignal.aaf3273 | PMID 27507649 Get It

Histone deacetylase 3 prevents chondrocytes from producing inflammatory mediators that prevent bone development.